Life ScienceCompany
ImmunoPrecise M&A Summary
ImmunoPrecise has acquired 3 companies, including 2 in the last 5 years.
ImmunoPrecise’s largest acquisition to date was in 2022, when it acquired BioStrand BV for $23M. ImmunoPrecise has acquired in 1 US state, and 3 countries. The Company’s most targeted sectors include internet software and services (34%) and life science (34%).
ImmunoPrecise Business Overview
Where is ImmunoPrecise headquartered?
ImmunoPrecise is headquartered in Victoria, British Columbia.
What is ImmunoPrecise’s revenue?
ImmunoPrecise disclosed revenue of 21M CAD for 2023 and 19M CAD for 2022.
How many employees does ImmunoPrecise have?
ImmunoPrecise has 102 employees.
What sector is ImmunoPrecise in?
ImmunoPrecise is a life science company.
When was ImmunoPrecise founded?
ImmunoPrecise was founded in 1983.
M&A Summary
-
M&A Total Activity3
- M&A Buy Activity3
- Total Sectors Invested 3
- Total Countries Invested 3
- M&A Buy/Sell Connections 1
Unlimited Searches
